glp 1 list FDA creates 'green list' of GLP-1 drug ingredients approved for entry in the U.S The GLP-1 Agonists and Obesity:

Here is what to watch for: Exercise intolerance, tiring sooner than usual or refusing to continue walks they previously completed without difficulty Generalised weakness, particularly in the hindquarters Lethargy and reduced engagement with normal activities and play Reduced appetite and progressive weight loss Episodes of fainting or collapse, particularly during or after exertion Breathlessness or laboured breathing, which may become more noticeable with mild activity Abdominal distension in cases where dilated cardiomyopathy has led to fluid accumulation A persistent, soft cough that is more noticeable at rest or at night, which can reflect early fluid in the lungs from cardiac involvement The cardiac signs are among the most significant

Dick, P., Grandjean, M., & Tissot, R

Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea

The red blood count is likely to be indirectly affected by LPS, as there is no evidence in the literature for a direct interaction of LPS with erythrocytes

Presented at the 38th annual meeting of the Obesity Society (TOS) held at ObesityWeek , November 26, 2020: Oral 084